Now Enrolling Patients with Recurrent Anaplastic Astrocytoma (rAA) Brain Cancer

Complete the form below to see if you or a loved one may qualify.

 

Are you eligible?

You may be eligible if:

  • Your doctor has told you that you have anaplastic astrocytoma (AA)

  • You have already been treated with radiation and a chemotherapy drug called temozolomide (also known as Temodar®)

  • Your doctor has told you that the tumor has recurred (come back) or has progressed (grown or changed) within the past 6 months

  • You completed radiation therapy more than 6 months ago 

  • You are an adult over the age of 18 years old

Travel Expenses

Participants may be eligible for study-related travel reimbursement.

What is the STELLAR study?

Brain cancer experts are conducting the STELLAR study to evaluate the use of eflornithine oral investigational medicine for treating recurrent anaplastic astrocytoma (rAA).

Eflornithine is an investigational product. An investigational product is one that has not been proven to be safe and effective for this use and is not licensed by the US Food and Drug Administration or any other government agency. An investigational product can only be administered in a research study.Participation details

Study Locations

Recruiting participants at selected medical centers in the United States, Belgium, Canada, Germany, Italy, France, United Kingdom and the Netherlands.

COMPLETE THIS FORM TO SEE IF YOU MAY QUALIFY

  • Who is the person interested in participating in this study?

    Myself
    A loved one

  • Is this person at least 18 years old?

    Yes
    No

  • Has this person been diagnosed with anaplastic astrocytoma?

    Yes
    No
    Don't Know

  • Has this person been treated with radiation and a chemotherapy drug called temozolomide (also known as Temodar®)?

    Yes
    No
    Don't Know

  • Has this person's tumor recurred (come back) or progressed (grown or changed) within the past 6 months?

    Yes
    No
    Don't Know

  • Has this person completed radiation therapy more than 6 months ago?

    Yes
    No
    Don't Know

  • Best time to contact you by phone:

    8am - Noon
    Noon - 2pm
    2pm - 5pm

  • Approximate distance willing to travel:

    Up to 150 miles
    Up to 500 miles
    Greater than 500 miles

For more information about the STELLAR study on the United States Government Clinical Study Registry. To find information about the STELLAR study in the European Union Clinical Study Register.